Where the blockbuster weight loss drug market stands today — and what’s coming next

Where the blockbuster weight loss drug market stands today — and what’s coming next

Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space.

Diabetes drug can help prevent the disease and support major weight loss

Tirzepatide, a medication sold under the names Mounjaro for diabetes and Zepbound for weight loss, has shown impressive results in helping people avoid developing diabetes. A new study found that it can reduce the risk of diabetes by up to 94% in people who are overweight or obese and already have signs of prediabetes. The […] The post Diabetes drug can help prevent the disease and support major weight loss appeared first on Knowridge Science Re…

Where the blockbuster weight loss drug market stands today — and what’s coming next – DG Verifications & Stats

In this article NOVO.B-DK LLY Follow your favorite stocksCREATE FREE ACCOUNTA combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters The appetite for blockbuster weight loss and diabetes drugs is far from satisfied.  From fresh competition to new uses, the market is quickly vaulting into a new stage of growth. But factors including insurance coverage,…

Where the blockbuster weight loss drug market stands today — and what’s coming next – RamaOnHealthcare

Key Points- The blockbuster weight loss drug market is entering a new chapter of growth.- Eli Lilly and Novo Nordisk are both focused on fighting for market share, ramping up supply, testing new uses for their medicines and bringing the next wave of obesity drugs to patients.- Trailing behind them is a slate of drugmakers [...]